Nikkei 225 Dips 0.37% Amid Bearish Sentiment; Oncolys BioPharma Soars 23.9%
The Japanese stock market showed mixed results, with the Nikkei 225 index down 0.37%. Over the past week, it has slightly decreased by 0.14%, but gained 0.17% over the last month. Large-cap stocks struggled, with a significant number declining, while mid-cap stocks faced even greater challenges. In contrast, small-cap stocks performed better, highlighted by Oncolys BioPharma's impressive 23.9% return. Overall, the market indicates a tough environment, particularly for mid and large-cap sectors, as evidenced by the advance-decline ratios across different market capitalizations.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
